search
Back to results

Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Postoperative Pain (Ampupain)

Primary Purpose

Phantom Limb Pain, Pain, Chronic

Status
Not yet recruiting
Phase
Phase 3
Locations
Colombia
Study Type
Interventional
Intervention
Epidural catheter
Continuous sciatic nerve block
Sponsored by
Universidad de Antioquia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Phantom Limb Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age over 18 years Being scheduled for above or below knee amputation or for bone remodeling of lower limb amputees Acceptance of continuous regional analgesic technique as part of their multimodal analgesia Exclusion Criteria: Traumatic cause of amputation Allergy to local anesthetics Contraindication for epidural technique or continuous blocks Stage 5 kidney disease Concomitant use of aspirin and clopidogrel Pregnancy status

Sites / Locations

  • Antioquia´s University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Epidural catheter

Continuous sciatic nerve block

Arm Description

Epidural catheter infusion of bupivacaine 0.1% (4-6 cc/h) at level L3-L4

Continuous sciatic catheter infusion of bupivacaine 0.1% (6-10 cc/h)

Outcomes

Primary Outcome Measures

Posoperative Pain
Pain score according to the daily NRS scale (Numeric Pain Rating Scale), Numeric Pain Rating Scale, for 15 days POP and subsequently monthly until completing 3 months. is scores from 0 to 10, 10 being the worst value.
Phantom Limp Pain
For this qualitative dichotomous outcome, you will ask about symptomatology referring to phantom limb pain for 15 days POP and subsequently monthly until completing 3 months, It will be qualified as positive if it presents any neuropathic symptom.

Secondary Outcome Measures

Phantom Limp Pain first Year
Presence of phantom limb pain on a monthly basis until completing 12 month, The patient will be asked about the appearance of any painful sensation described as stabbing, shooting, electric shock, dull, tight pain and/or cramp in the anatomical site where the amputated limb would be, evaluating the presence or absence of the same (s). This will be questioned every day for 15 POPs days and monthly follow-up will continue via telephone until completing 3 months.
Opioid Consumption
the total consumption in mg of morphine or its equivalent at 12, 24 and 36 h POP will be evaluated.
Incidence of nausea and vomiting POP
Incidence of nausea and vomiting POP in each group: the appearance of nausea or vomiting at 12, 24 and 36 h POP will be asked.
Incidence of adverse effects
any appearance of hematoma, hypotension (defined as SBP less than 90 mmHg or a 30% decrease in baseline MAP) or bradycardia (HR less than 60 bpm) is defined.
Days of hospital stay
Days of hospital stay through study completion
Mortality
Mortality in the first Year

Full Information

First Posted
March 9, 2022
Last Updated
November 2, 2022
Sponsor
Universidad de Antioquia
search

1. Study Identification

Unique Protocol Identification Number
NCT05608733
Brief Title
Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Postoperative Pain
Acronym
Ampupain
Official Title
Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Prevention of Acute Postoperative Pain and Phantom Limb Pain: A Triple-blind Randomized Controlled Non-inferiority Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 2022 (Anticipated)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
July 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universidad de Antioquia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Controlled clinical trial of two parallel groups, with random assignment 1:1, non-inferiority, blinded for the patient, for who administers the intervention and for who analyzes the data. 112 participants
Detailed Description
Controlled clinical trial of two parallel groups, with random assignment 1:1, non-inferiority, blinded for the patient, for who administers the intervention and for who analyzes the data. 112 participants Outcomes: Primary: Numeric rating scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain) was used for pain assessments daily for 15 days and subsequently monthly until completing 3 months. Co-primary: Assessment of symptomatology related to phantom limb pain daily for 15 days POP and subsequently monthly until completing 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Phantom Limb Pain, Pain, Chronic

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
112 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Epidural catheter
Arm Type
Experimental
Arm Description
Epidural catheter infusion of bupivacaine 0.1% (4-6 cc/h) at level L3-L4
Arm Title
Continuous sciatic nerve block
Arm Type
Active Comparator
Arm Description
Continuous sciatic catheter infusion of bupivacaine 0.1% (6-10 cc/h)
Intervention Type
Drug
Intervention Name(s)
Epidural catheter
Other Intervention Name(s)
Epidural Analgesia
Intervention Description
Bony landmarks and the space between the lower lumbar vertebrae are identified. Subsequently, infiltration of the skin and subcutaneous cellular tissue with local anesthetic (Lidocaine 2% without epinephrine) is performed at the site to be punctured. A 17G Tuohy needle is inserted 2-4 cm through the skin, then the mandrel is removed, the low-resistance syringe is connected, and the loss of resistance is checked using the air or liquid technique, depending on the preference of the anesthesiologist. . Appreciating the loss of resistance in the embolus, the mandrel is then withdrawn and the epidural catheter is advanced to leave it an additional 5 cm inside the epidural space.
Intervention Type
Drug
Intervention Name(s)
Continuous sciatic nerve block
Other Intervention Name(s)
Periferical continuous block
Intervention Description
The patient is placed in the prone or supine position with the limb to be blocked flexed at 90°. Using a high-frequency linear transducer and using sterile technique, the popliteal sciatic nerve is identified in an axial axis. A 17G Tuohy needle is inserted plane and medial. Saline solution (5 ml) is applied to open the perineural space. Adequate hydrodissection and donut sign in the nerve are observed..A perineural catheter is then advanced 5 cm beyond the tip of the needle. The catheter is fixed with stitches and a transparent sterile dressing is placed.
Primary Outcome Measure Information:
Title
Posoperative Pain
Description
Pain score according to the daily NRS scale (Numeric Pain Rating Scale), Numeric Pain Rating Scale, for 15 days POP and subsequently monthly until completing 3 months. is scores from 0 to 10, 10 being the worst value.
Time Frame
3 months
Title
Phantom Limp Pain
Description
For this qualitative dichotomous outcome, you will ask about symptomatology referring to phantom limb pain for 15 days POP and subsequently monthly until completing 3 months, It will be qualified as positive if it presents any neuropathic symptom.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Phantom Limp Pain first Year
Description
Presence of phantom limb pain on a monthly basis until completing 12 month, The patient will be asked about the appearance of any painful sensation described as stabbing, shooting, electric shock, dull, tight pain and/or cramp in the anatomical site where the amputated limb would be, evaluating the presence or absence of the same (s). This will be questioned every day for 15 POPs days and monthly follow-up will continue via telephone until completing 3 months.
Time Frame
1 year
Title
Opioid Consumption
Description
the total consumption in mg of morphine or its equivalent at 12, 24 and 36 h POP will be evaluated.
Time Frame
36 hours
Title
Incidence of nausea and vomiting POP
Description
Incidence of nausea and vomiting POP in each group: the appearance of nausea or vomiting at 12, 24 and 36 h POP will be asked.
Time Frame
36 hours
Title
Incidence of adverse effects
Description
any appearance of hematoma, hypotension (defined as SBP less than 90 mmHg or a 30% decrease in baseline MAP) or bradycardia (HR less than 60 bpm) is defined.
Time Frame
1 year
Title
Days of hospital stay
Description
Days of hospital stay through study completion
Time Frame
during the time of hospitalization, on average 10 days
Title
Mortality
Description
Mortality in the first Year
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
Posoperative Satisfaction
Description
Postoperative satisfaction measured with the EVAN LR scale (evaluation of local anesthetic satisfaction). It consists of a self-reported scale that measures satisfaction in the postoperative period of patients undergoing regional anesthesia in different surgical models (51), with an evaluation of 19 items structured in a global index and five unweighted dimensions, each of which covers some aspects such as Attention (4 items), Information (5 items), Discomfort (4 items), Waiting (2 items) and Pain (4 items). has a score for questions between 20 and 100 points, the lower the score, the lower satisfaction by dimension
Time Frame
36 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age over 18 years Being scheduled for above or below knee amputation or for bone remodeling of lower limb amputees Acceptance of continuous regional analgesic technique as part of their multimodal analgesia Exclusion Criteria: Traumatic cause of amputation Allergy to local anesthetics Contraindication for epidural technique or continuous blocks Stage 5 kidney disease Concomitant use of aspirin and clopidogrel Pregnancy status
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniela González, Md
Phone
3122690961
Email
daniela.gonzalezg@udea.edu.co
First Name & Middle Initial & Last Name or Official Title & Degree
Laura Lopez Agudelo, Md
Phone
3148874442
Email
laura.lopez9@udea.edu.co
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mario Zamudio, Prof
Organizational Affiliation
IPS universitaria
Official's Role
Study Director
Facility Information:
Facility Name
Antioquia´s University
City
Medellin
Country
Colombia

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
public bases of data
Citations:
PubMed Identifier
31248645
Citation
Edgley C, Hogg M, De Silva A, Braat S, Bucknill A, Leslie K. Severe acute pain and persistent post-surgical pain in orthopaedic trauma patients: a cohort study. Br J Anaesth. 2019 Sep;123(3):350-359. doi: 10.1016/j.bja.2019.05.030. Epub 2019 Jun 24.
Results Reference
background
PubMed Identifier
29973967
Citation
De Jong R, Shysh AJ. Development of a Multimodal Analgesia Protocol for Perioperative Acute Pain Management for Lower Limb Amputation. Pain Res Manag. 2018 Jun 3;2018:5237040. doi: 10.1155/2018/5237040. eCollection 2018.
Results Reference
background
PubMed Identifier
12579385
Citation
Gehling M, Tryba M. [Prophylaxis of phantom pain: is regional analgesia ineffective?]. Schmerz. 2003 Jan;17(1):11-9. doi: 10.1007/s00482-002-0198-2. German.
Results Reference
background

Learn more about this trial

Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Postoperative Pain

We'll reach out to this number within 24 hrs